Reading that again, perhaps the chairmans letter trumps everything that was said about PBT2 in the 2017 report about development opportunities review.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025